Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calpain-2, also known as m-calpain or calcium-activated neutral protease II, is a large catalytic subunit of the calpain family—calcium-dependent, non-lysosomal cysteine proteases found in most mammalian tissues[1][6]. It typically exists as a heterodimer with the common small regulatory subunit (CAPNS1/CAPN4). Calpain-2 requires higher calcium concentrations for activation than its close paralog calpain-1 and is involved in the limited proteolysis of key structural and regulatory proteins. Its critical functions include modulation of the cytoskeleton for cell migration, cell signal transduction, apoptosis, and cell cycle events[1][3][6]. Dysregulated calpain-2 activity is implicated in various pathologies, including cancer, neurodegenerative, cardiovascular, and inflammatory diseases. While calpain inhibitors have shown preclinical efficacy as therapeutic agents, drug development is complicated by the enzyme family's ubiquitous expression, structural similarity among isoforms, and essential roles in normal physiology[4][6].
Inhibition of protease activity (for inhibitors: block the catalytic cysteine in the active site) Reduction of substrate cleavage and downstream cellular effects
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calpain-2 (None).